Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$2.36 - $3.35 $68,746 - $97,585
-29,130 Reduced 50.04%
29,087 $73,000
Q4 2022

Feb 14, 2023

BUY
$2.58 - $4.68 $150,199 - $272,455
58,217 New
58,217 $156,000
Q4 2021

Feb 14, 2022

SELL
$7.03 - $13.03 $33,947 - $62,921
-4,829 Reduced 6.44%
70,158 $493,000
Q3 2021

Nov 15, 2021

BUY
$11.11 - $17.84 $238,720 - $383,328
21,487 Added 40.16%
74,987 $847,000
Q2 2021

Aug 16, 2021

SELL
$13.68 - $22.34 $900,144 - $1.47 Million
-65,800 Reduced 55.16%
53,500 $967,000
Q1 2021

May 17, 2021

SELL
$9.0 - $63.91 $1.27 Million - $9.04 Million
-141,388 Reduced 54.24%
119,300 $2.71 Million
Q4 2020

Feb 10, 2021

BUY
$4.82 - $10.1 $1.15 Million - $2.42 Million
239,238 Added 1115.33%
260,688 $2.15 Million
Q3 2020

Nov 16, 2020

BUY
$4.7 - $8.7 $100,815 - $186,614
21,450 New
21,450 $104,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $832M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Bluefin Capital Management, LLC Portfolio

Follow Bluefin Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluefin Capital Management, LLC with notifications on news.